BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 19309345)

  • 1. Lentigo maligna--outcomes of treatment with Q-switched Nd:YAG and alexandrite lasers.
    Madan V; August PJ
    Dermatol Surg; 2009 Apr; 35(4):607-11; discussion 611-2. PubMed ID: 19309345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Letter: Regarding lentigo maligna: outcomes of treatment with Q-switched neodymium-doped yttrium aluminum garnet and alexandrite lasers.
    Madan V; August PJ
    Dermatol Surg; 2010 Mar; 36(3):437. PubMed ID: 20402954
    [No Abstract]   [Full Text] [Related]  

  • 3. Letter: regarding lentigo maligna: outcomes of treatment with q-switched neodymium-doped yttrium aluminum garnet and alexandrite lasers.
    Lawrence N; Nemeth S
    Dermatol Surg; 2010 Feb; 36(2):274. PubMed ID: 20402962
    [No Abstract]   [Full Text] [Related]  

  • 4. Lentigo maligna of the head and neck. Results of treatment by radiotherapy.
    Tsang RW; Liu FF; Wells W; Payne DG
    Arch Dermatol; 1994 Aug; 130(8):1008-12. PubMed ID: 8053696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fractionated radiotherapy of lentigo maligna and lentigo maligna melanoma in 64 patients.
    Schmid-Wendtner MH; Brunner B; Konz B; Kaudewitz P; Wendtner CM; Peter RU; Plewig G; Volkenandt M
    J Am Acad Dermatol; 2000 Sep; 43(3):477-82. PubMed ID: 10954659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Grenz ray treatment of lentigo maligna and early lentigo maligna melanoma.
    Hedblad MA; Mallbris L
    J Am Acad Dermatol; 2012 Jul; 67(1):60-8. PubMed ID: 22030019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-fluence Q-switched 1,064-nm neodymium-doped yttrium aluminum garnet laser for the treatment of facial partial unilateral lentiginosis in Koreans.
    Lee Y; Choi EH; Lee SW
    Dermatol Surg; 2012 Jan; 38(1):31-7. PubMed ID: 22093176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lentigo maligna/lentigo maligna melanoma: current state of diagnosis and treatment.
    McKenna JK; Florell SR; Goldman GD; Bowen GM
    Dermatol Surg; 2006 Apr; 32(4):493-504. PubMed ID: 16681656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbon dioxide laser treatment for lentigo maligna: a retrospective review comparing 3 different treatment modalities.
    Lee H; Sowerby LJ; Temple CL; Yu E; Moore CC
    Arch Facial Plast Surg; 2011; 13(6):398-403. PubMed ID: 22106185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mapped serial excision for periocular lentigo maligna and lentigo maligna melanoma.
    Malhotra R; Chen C; Huilgol SC; Hill DC; Selva D
    Ophthalmology; 2003 Oct; 110(10):2011-8. PubMed ID: 14522781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of two Q-switched lasers and a short-pulse erbium-doped yttrium aluminum garnet laser for treatment of cosmetic tattoos containing titanium and iron in an animal model.
    Wang CC; Huang CL; Yang AH; Chen CK; Lee SC; Leu FJ
    Dermatol Surg; 2010 Nov; 36(11):1656-63. PubMed ID: 20840495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Q-switched neodymium:yttrium-aluminum-garnet laser treatment of lentigo maligna.
    Orten SS; Waner M; Dinehart SM; Bardales RH; Flock ST
    Otolaryngol Head Neck Surg; 1999 Mar; 120(3):296-302. PubMed ID: 10064628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of lentigo maligna with combination laser therapy: recurrence at 8 months after initial resolution.
    Iyer S; Goldman M
    J Cosmet Laser Ther; 2003 Apr; 5(1):49-52. PubMed ID: 12745600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of long-pulsed alexandrite and Nd:YAG lasers, individually and in combination, for leg hair reduction: an assessor-blinded, randomized trial with 18 months of follow-up.
    Davoudi SM; Behnia F; Gorouhi F; Keshavarz S; Nassiri Kashani M; Rashighi Firoozabadi M; Firooz A
    Arch Dermatol; 2008 Oct; 144(10):1323-7. PubMed ID: 18936396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical margins for lentigo maligna and lentigo maligna melanoma: the technique of mapped serial excision.
    Huilgol SC; Selva D; Chen C; Hill DC; James CL; Gramp A; Malhotra R
    Arch Dermatol; 2004 Sep; 140(9):1087-92. PubMed ID: 15381549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of lentigo maligna and lentigo maligna melanoma: seminars in surgical oncology.
    Arlette JP; Trotter MJ; Trotter T; Temple CL
    J Surg Oncol; 2004 Jul; 86(4):179-86. PubMed ID: 15221924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Staged excision versus Mohs micrographic surgery for lentigo maligna and lentigo maligna melanoma.
    Walling HW; Scupham RK; Bean AK; Ceilley RI
    J Am Acad Dermatol; 2007 Oct; 57(4):659-64. PubMed ID: 17870430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of 2940-nm ER:YAG laser for the treatment of lentigo maligna.
    Fikrle T; Divišová B; Šuchmannová J; Pizinger K
    J Dtsch Dermatol Ges; 2019 Apr; 17(4):425-431. PubMed ID: 30933436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative evaluation of long-pulse alexandrite and long-pulse Nd:YAG laser systems used individually and in combination for axillary hair removal.
    Khoury JG; Saluja R; Goldman MP
    Dermatol Surg; 2008 May; 34(5):665-70; discussion 670-1. PubMed ID: 18261098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Staged excision for lentigo maligna and lentigo maligna melanoma: A retrospective analysis of 117 cases.
    Hazan C; Dusza SW; Delgado R; Busam KJ; Halpern AC; Nehal KS
    J Am Acad Dermatol; 2008 Jan; 58(1):142-8. PubMed ID: 18029055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.